Silverback Therapeutics, Inc.

NasdaqGM:SBTX Stock Report

Market Cap: US$211.7m

This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

Silverback Therapeutics Management

Management criteria checks 0/4

Key information

Jeffrey Pepe

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownership0.1%
Management average tenureless than a year
Board average tenure2.6yrs

Recent management updates

Have Insiders Been Buying Silverback Therapeutics, Inc. (NASDAQ:SBTX) Shares This Year?

Mar 04
Have Insiders Been Buying Silverback Therapeutics, Inc. (NASDAQ:SBTX) Shares This Year?

Recent updates

Here's Why We're Not Too Worried About Silverback Therapeutics' (NASDAQ:SBTX) Cash Burn Situation

Jul 13
Here's Why We're Not Too Worried About Silverback Therapeutics' (NASDAQ:SBTX) Cash Burn Situation

Companies Like Silverback Therapeutics (NASDAQ:SBTX) Are In A Position To Invest In Growth

Aug 30
Companies Like Silverback Therapeutics (NASDAQ:SBTX) Are In A Position To Invest In Growth

Silverback Therapeutics (NASDAQ:SBTX) Is In A Good Position To Deliver On Growth Plans

May 15
Silverback Therapeutics (NASDAQ:SBTX) Is In A Good Position To Deliver On Growth Plans

Have Insiders Been Buying Silverback Therapeutics, Inc. (NASDAQ:SBTX) Shares This Year?

Mar 04
Have Insiders Been Buying Silverback Therapeutics, Inc. (NASDAQ:SBTX) Shares This Year?

Silverback Therapeutics is a buy at Goldman Sachs on unique therapy platform

Dec 30

CEO

Jeffrey Pepe

less than a year

Tenure

Mr. Jeffrey C. Pepe, Ph D., J.D., serves as Interim Chief Executive Officer at Silverback Therapeutics, Inc. since September 2, 2022. Dr. Pepe serves as Corporate Secretary at Silverback Therapeutics, Inc....


Leadership Team

NamePositionTenureCompensationOwnership
Peter Thompson
Co-Founder & Chairman of the Board of Directors6.6yrsUS$551.64k0%
$ 0
Jeffrey Pepe
Interim CEOless than a yearno data0.15%
$ 312.4k
Russ Hawkinson
Senior VP of Financeless than a yearno data0.0040%
$ 8.4k
Miguel Arcinas
Vice President of Corporate Development & Investor Relations1.8yrsno datano data
Jen More
Director of Human Resourcesno datano datano data
Sue Hamke
Senior Vice President of Clinical Operationsno datano datano data
Dario Gobunquin
Senior Director of Accounting & Controllerno datano datano data

0.2yrs

Average Tenure

Experienced Management: SBTX's management team is not considered experienced ( 0.2 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Peter Thompson
Co-Founder & Chairman of the Board of Directors6.6yrsUS$551.64k0%
$ 0
Jonathan Root
Independent Director2.7yrsUS$329.71k0.27%
$ 568.5k
Vickie Capps
Independent Director2.4yrsUS$341.21k0.17%
$ 367.6k
Laura Shawver
Director2.6yrsUS$821.50k0.45%
$ 947.0k
Robert Hershberg
Independent Director6.8yrsUS$330.21k0%
$ 0
Andrew Kenneth Powell
Independent Director2.1yrsUS$332.21k0%
$ 0
Saqib Islam
Independent Director5.3yrsUS$328.26k0.043%
$ 91.0k
Maria Koehler
Independent Director1.7yrsUS$986.04k0%
$ 0

2.6yrs

Average Tenure

62yo

Average Age

Experienced Board: SBTX's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.